BRRGF (Oncoinvent ASA) Total Liabilities: $5.80 Mil (As of Dec. 2025)


BRRGF Oncoinvent ASA BRRGF
36 GF Score
Price $97.09
GF Value $1,788.00
! 4 Warning Signs
View Full Analysis

What is Oncoinvent ASA Total Liabilities?

Oncoinvent ASA BRRGF 36 Total Liabilities is $5.80 Mil as of Dec. 2025. GuruFocus rates BRRGF with a GF Score™ of 36/100 and a GF Value™ of $1,788.00. The stock has 4 warning signs investors should review.

Oncoinvent ASA's Total Liabilities for the quarter that ended in Dec. 2025 was $5.80 Mil.

Oncoinvent ASA's quarterly Total Liabilities declined from Dec. 2024 ($5.59 Mil) to Jun. 2025 ($1.97 Mil) but then increased from Jun. 2025 ($1.97 Mil) to Dec. 2025 ($5.80 Mil).

Oncoinvent ASA's annual Total Liabilities increased from Dec. 2023 ($4.44 Mil) to Dec. 2024 ($5.59 Mil) and increased from Dec. 2024 ($5.59 Mil) to Dec. 2025 ($5.80 Mil).

Oncoinvent ASA Total Liabilities Historical Data

* Premium members only.

The historical data trend for Oncoinvent ASA's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncoinvent ASA Total Liabilities Chart

Oncoinvent ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.33 7.92 4.44 5.59 5.80

Oncoinvent ASA Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.44 4.07 5.59 1.97 5.80
BRRGF
36GF Score
Oncoinvent ASA BRRGF
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oncoinvent ASA Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Oncoinvent ASA's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=5.735+(0.067+-0.0010000000000002
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=5.80

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=20.279-14.478
=5.80

Oncoinvent ASA's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=5.735+(0.067+-0.0010000000000002
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=5.80

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=20.279-14.478
=5.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $5.80 Mil mean?
Oncoinvent ASA (BRRGF) has a Total Liabilities of $5.80 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Oncoinvent ASA and its competitors.
Is Oncoinvent ASA's Total Liabilities too high?
Oncoinvent ASA's current Total Liabilities is $5.80 Mil. Overall, Oncoinvent ASA has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Oncoinvent ASA's Total Liabilities compare to VRTX and REGN?
Oncoinvent ASA's Total Liabilities of $5.80 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Oncoinvent ASA and its competitors. Oncoinvent ASA's current Total Liabilities is $5.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncoinvent ASA stock overvalued right now?
Oncoinvent ASA (BRRGF) has a current Total Liabilities of $5.80 Mil. The stock's GF Value™ is $1,788.00, compared to a current price of $97.09 — trading 94.6% below its estimated fair value. The current Total Liabilities is $5.80 Mil. Oncoinvent ASA's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Oncoinvent ASA (BRRGF), the current Total Liabilities is $5.80 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oncoinvent ASA (BRRGF) Overvalued in 2026?

Based on GuruFocus' analysis, Oncoinvent ASA stock appears to be undervalued. The current stock price of $97.09 is trading 94.6% below its estimated GF Value™ of $1,788.00.

Key valuation signals for BRRGF:

  • Total Liabilities: $5.80 Mil
  • GF Value™: $1,788.00 vs. price of $97.09 (94.6% below fair value)
  • GF Score™: 36/100 with 4 warning signs

No single metric tells the full story. See the BRRGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oncoinvent ASA Business Description

Address Gullhaugveien 7, Oslo, NOR, 0484
Oncoinvent ASA is a clinical-stage biotechnology company developing novel radiopharmaceutical therapies against cancer. Its key product candidate is Radspherin, a receptor-independent alpha radiation therapy that leverages the anatomy of the abdominal cavity to destroy residual micrometastases using a single, localized dose of alpha radiation. Radspherin is currently in clinical development in two indications: peritoneal metastasis from ovarian and colorectal cancer, but it is also relevant for treating peritoneal metastasis from other cancer types and potentially metastatic cancer in other body cavities. Geographically, the company operates in Norway.
36GF Score

Get the complete analysis for BRRGF

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$97.09
Price
$1,788.00
GF Value